Linda Moy

Author PubWeight™ 27.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science 2002 9.59
2 Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 2005 2.05
3 Update on imaging of the postsurgical breast. Radiographics 2014 1.49
4 Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol 2008 1.00
5 Ductal carcinoma in situ of the breasts: review of MR imaging features. Radiographics 2013 0.99
6 Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement. J Magn Reson Imaging 2013 0.94
7 Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle. Radiology 2013 0.90
8 Breast MRI at 7 Tesla with a bilateral coil and T1-weighted acquisition with robust fat suppression: image evaluation and comparison with 3 Tesla. Eur Radiol 2013 0.86
9 Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model. NMR Biomed 2011 0.86
10 Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training. AJR Am J Roentgenol 2014 0.85
11 Outcome of high-risk lesions at MRI-guided 9-gauge vacuum- assisted breast biopsy. AJR Am J Roentgenol 2014 0.84
12 Primary large cell neuroendocrine carcinoma of the breast, a case report with an unusual clinical course. Breast J 2015 0.84
13 Breast MRI at 7 Tesla with a bilateral coil and robust fat suppression. J Magn Reson Imaging 2013 0.83
14 Differentiation of malignant and benign breast lesions using magnetization transfer imaging and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2012 0.82
15 Short interval follow-up after a benign concordant MR-guided vacuum assisted breast biopsy--is it worthwhile? Eur Radiol 2014 0.82
16 Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magn Reson Imaging 2012 0.80
17 Screening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same. Int J Breast Cancer 2013 0.80
18 Optimizing 1.5-Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts. Magn Reson Imaging Clin N Am 2010 0.79
19 The role of dynamic contrast-enhanced screening breast MRI in populations at increased risk for breast cancer. Womens Health (Lond Engl) 2014 0.77
20 Radiologic-pathologic correlation at breast MR imaging: what is the appropriate management for high-risk lesions? Magn Reson Imaging Clin N Am 2013 0.77
21 Imaging features and management of high-risk lesions on contrast-enhanced dynamic breast MRI. AJR Am J Roentgenol 2012 0.77
22 Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation. Clin Nucl Med 2016 0.76
23 Breast MRI. Preface. Magn Reson Imaging Clin N Am 2010 0.75
24 Comprehensive Dynamic Contrast-Enhanced 3D Magnetic Resonance Imaging of the Breast With Fat/Water Separation and High Spatiotemporal Resolution Using Radial Sampling, Compressed Sensing, and Parallel Imaging. Invest Radiol 2017 0.75
25 Compressed Sensing for Breast MRI: Resolving the Trade-Off Between Spatial and Temporal Resolution. Invest Radiol 2017 0.75
26 Sonographically guided marker placement for confirmation of removal of mammographically occult lesions after localization. AJR Am J Roentgenol 2008 0.75